KC
KRBP

Kepos Capital’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Kepos Capital’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,567
Closed -$655K – 627
2022
Q1 		$655K Hold
25,567
– – 0.05% 197
2021
Q4 		$1.17M Hold
25,567
– – 0.1% 188
2021
Q3 		$2.35M Hold
25,567
– – 0.16% 247
2021
Q2 		$3.69M Buy
+25,567
New +$6.41M 0.27% 191

Other funds holding KRBP

ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $401M AUM 14.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kepos Capital's KRBP Position: Q2 2022 in Review

Kepos Capital sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q2 2022, closing a stake of 25,567 shares — an estimated $655K sold.

Kepos Capital first reported a position in KRBP in Q2 2021 and held it in 4 quarters. The position peaked at $3.69M in Q2 2021. 17 funds tracked by Wall St. Rank hold KRBP as of Q2 2022.

  • Kepos Capital reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Kepos Capital sold 25,567 Kiromic BioPharma, Inc. Common Stock shares in Q2 2022, an estimated $655K.
  • Kepos Capital first reported a position in Kiromic BioPharma, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Kepos Capital's Kiromic BioPharma, Inc. Common Stock position peaked at $3.69M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.